 AI-Driven Learning with Med-Challenger: Supplemental Info at Your Fingertips
This free course showcases the capabilities of Med-Challenger’s AI-driven large language model (LLM) and demonstrates how it can enhance your medical learning experience. Watch the short, 25-second video to see just how easy it is to download your free course today.
Free AI-Driven Sample Course
 Diagnostic Testing Disparities Identified Between Black and White Patients
A study of 3.6 million encounters between 2016 and 2018 measured testing disparities among ethnic groups for nonspecific diagnoses in the ED. The Epocrates article is somewhat brief. The summary in the actual publication (linked below) provides additional regional information and references related to the study.
Diagnostic Testing Disparities Identified Between Black and White Patients - Epocrates, JAMA Network
Race and Ethnicity and Diagnostic Testing for Common Conditions in the Acute Care Setting - PubMed
 America is Increasingly Dependent on Foreign Doctors − but Their Path to Immigration is Getting Harder
The statistics in this article are generally accurate. The percentage of U.S. citizens receiving their medical education outside the U.S., primarily in Canada and the Caribbean, is high, which reflects a different issue with medical education in the U.S. However, about 25% of practicing physicians are foreign-born. H-1B visas grew in popularity but began to decline in the early 2000s, a trend that has accelerated in the 2020s. The current cap is 85,000.
Medical school admissions in the U.S. are at about 40% of qualified applicants. In the 2023 match, 40,375 residency slots were offered.
America is Increasingly Dependent on Foreign Doctors − but Their Path to Immigration is Getting Harder 
Protecting Patients from Deceptive Drug Ads Online Act Introduced – Policy & Medicine
There’s a significant gap in FDA regulation when it comes to the promotion of prescription drugs by manufacturers. 'Influencers' and deceptive indirect online advertising are not currently regulated by the FDA. The proposed bill would allow the FDA to issue warnings and fines for communications that result in a financial benefit to the speaker/promoter. It would exclude patient care, medical research, and opinions, and is primarily aimed at commercial claims made by professional marketers.
The FDA currently lacks an effective enforcement mechanism to police social media, but the bill would provide tools to address some of the most egregious violations.
Protecting Patients from Deceptive Drug Ads Online Act Introduced – Policy & Medicine - Policy & Medicine
|
